Owner Neuropore Therapies, Inc.

Inventors Masliah, Eliezer; Rockenstein, Edward M.; Wrasidlo, Wolfgang; Tsigelny, Igor Flint

Agent Davies Collison Cave

Pub. Number AU-A-2010339841

PCT Pub. Number WO2011/084642

Priority 61/287,082 16.12.09 US

Filing date 16 December 2010

Wipo publication date 14 July 2011

C07D 403/12 Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 31/404

A61K 31/4184

A61K 31/4196 - 1,2,4-Triazoles

A61K 31/422 - not condensed and containing further heterocyclic rings

A61K 31/427 - not condensed and containing further heterocyclic rings

A61K 31/519 - ortho- or peri-condensed with heterocyclic rings

A61K 31/52

A61P 25/16 Drugs for disorders of the nervous system

A61P 25/28 Drugs for disorders of the nervous system

C07D 413/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 473/00 Heterocyclic compounds containing purine ring systems

C07D 487/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups